NasdaqCM - Delayed Quote • USD
Fortress Biotech, Inc. (FBIO)
At close: 4:00 PM EDT
Earnings Estimate
CURRENCY IN USD | Current Qtr. (Mar 2024) | Next Qtr. (Jun 2024) | Current Year (2024) | Next Year (2025) |
---|---|---|---|---|
No. of Analysts | 3 | 3 | 3 | 3 |
Avg. Estimate | -1.73 | -1.58 | -5.8 | -4.68 |
Low Estimate | -2.6 | -2.24 | -8.03 | -6.91 |
High Estimate | -1.13 | -1.07 | -4.25 | -2.9 |
Year Ago EPS | -3.15 | -3.6 | -8.47 | -5.8 |
Revenue Estimate
CURRENCY IN USD | Current Qtr. (Mar 2024) | Next Qtr. (Jun 2024) | Current Year (2024) | Next Year (2025) |
---|---|---|---|---|
No. of Analysts | 3 | 3 | 3 | 3 |
Avg. Estimate | 14.13M | 15.31M | 71.22M | 109.83M |
Low Estimate | 13.7M | 14.94M | 59.69M | 77.8M |
High Estimate | 14.36M | 15.85M | 88.86M | 134.64M |
Year Ago Sales | 12.43M | 17.39M | 84.51M | 71.22M |
Sales Growth (year/est) | 13.70% | -11.90% | -15.70% | 54.20% |
Earnings History
CURRENCY IN USD | 3/31/2023 | 6/30/2023 | 9/30/2023 | 12/31/2023 |
---|---|---|---|---|
EPS Est. | -3 | -3.41 | -3.21 | -1.97 |
EPS Actual | -3.15 | -3.6 | -0.94 | -1.28 |
Difference | -0.15 | -0.19 | 2.27 | 0.69 |
Surprise % | -5.00% | -5.60% | 70.70% | 35.00% |
EPS Trend
CURRENCY IN USD | Current Qtr. (Mar 2024) | Next Qtr. (Jun 2024) | Current Year (2024) | Next Year (2025) |
---|---|---|---|---|
Current Estimate | -1.73 | -1.58 | -5.8 | -4.68 |
7 Days Ago | -1.73 | -1.58 | -5.8 | -4.68 |
30 Days Ago | -1.41 | -1.3 | -2.9 | -2.23 |
60 Days Ago | -3 | -2.4 | -3.2 | -0.96 |
90 Days Ago | -3 | -2.4 | -3.68 | 0.11 |
EPS Revisions
CURRENCY IN USD | Current Qtr. (Mar 2024) | Next Qtr. (Jun 2024) | Current Year (2024) | Next Year (2025) |
---|---|---|---|---|
Up Last 7 Days | -- | -- | -- | -- |
Up Last 30 Days | 2 | 1 | 1 | 2 |
Down Last 7 Days | -- | -- | -- | -- |
Down Last 30 Days | -- | -- | -- | -- |
Growth Estimates
CURRENCY IN USD | FBIO | Industry | Sector | S&P 500 |
---|---|---|---|---|
Current Qtr. | 45.10% | -- | -- | 0.40% |
Next Qtr. | 56.10% | -- | -- | 9.90% |
Current Year | 31.50% | -- | -- | 4.30% |
Next Year | 19.30% | -- | -- | 13.40% |
Next 5 Years (per annum) | 25.50% | -- | -- | 11.09% |
Past 5 Years (per annum) | -- | -- | -- | -- |
Research Analysis
Upgrades & Downgrades
Initiated | Alliance Global Partners: Buy | 3/19/2024 |
Maintains | Roth MKM: Buy to Buy | 11/29/2023 |
Related Tickers
MBIO Mustang Bio, Inc.
0.3597
+5.79%
SLN Silence Therapeutics plc
22.51
+0.04%
CKPT Checkpoint Therapeutics, Inc.
1.4350
-1.03%
ATXI Avenue Therapeutics, Inc.
0.1340
+3.00%
OCUP Ocuphire Pharma, Inc.
1.5400
+1.99%
EYEN Eyenovia, Inc.
0.5426
+5.05%
ALT Altimmune, Inc.
7.57
+1.34%
PTN Palatin Technologies, Inc.
1.7500
+1.74%
ALVR AlloVir, Inc.
0.7909
+3.66%
SLNCF Silence Therapeutics plc
8.00
0.00%